Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Unraveling Health Disparities Across Cause-Specific Outcomes Associated with Emerging Air Pollutants: Evidence on Black Carbon and Ultrafine Particles in Buffalo, New York.

Environmental research·2026

Same author

Regenerative Nanoscaffolds for Chronic Tympanic Membrane Perforation: From Bench to Clinical Translation.

Tissue engineering. Part A·2026

Same author

Thermal Recovery of Damaged Hydrophobic Coatings in EWOD Devices Using an Integrated Mesh-Patterned Heater.

Micromachines·2026

Same author

Modeling the Clinical Reasoning Workflow: A Dynamic, Time-Aware CDSS for the Emergency Department.

Studies in health technology and informatics·2026

Same author

Virtual Reality-Based Stabilization for Health Care Workers with Post-Traumatic Stress Symptoms: A Preliminary Randomized Controlled Trial.

Cyberpsychology, behavior and social networking·2026

Same author

MLC1 alteration in human iPSCs give rise to disease-like cellular vacuolation phenotype in the astrocyte lineage.

Orphanet journal of rare diseases·2026

Same journal

Oxygen-Independent Supramolecular Nanoplatform for Photothermal-Thermodynamic Therapy against Periodontal Anaerobic Infections.

Advanced healthcare materials·2026

Same journal

An All-in-One Nanoplatform for Synergistic Anti-Infection and Healing of Diabetic Wounds via Photothermal-Gas Therapy.

Advanced healthcare materials·2026

Same journal

Bioactive Hydrogels with D-Amino Acid RGD Mimics: A Therapeutic Strategy for Expeditious Infected Wound Closure.

Advanced healthcare materials·2026

Same journal

An Asymmetric Dura-Inspired Collagen Hydrogel Patch with Integrated Dense-Porous Architecture Enabled by Dual-Channel Freeze Casting.

Advanced healthcare materials·2026

Same journal

Pathology-Targeted Nanoparticles Guided by Peptide Remodel the Periodontal Microenvironment for Periodontitis Therapy.

Advanced healthcare materials·2026

Same journal

Gellan Gum Fluid Gel System for Controlled-Delivery of Cytokine-Licensed MSC-EVs to Enhance Corneal Repair in Limbal Stem Cell Deficiency.

Advanced healthcare materials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

Published on: March 28, 2025

Ultra-Tiny Scale Technology for iPSC-Based Cardiac Tissue Engineering.

Chaeyeon Park^1,2,3,4, Woochan Kim^1,2,3,4, Harshita Sharma^1,2,3,4

¹Department of Convergence Biosystems Engineering, Chonnam National University, Gwangju, Republic of Korea.

Advanced Healthcare Materials

|December 2, 2025

Summary

This summary is machine-generated.

Nanoscale engineering enhances the maturation of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) by mimicking the cardiac microenvironment. This approach improves cardiac tissue regeneration, drug screening, and disease modeling for regenerative medicine.

Keywords:

cardiac modeling cardiac tissue engineering cardiomyocyte maturation induced pluripotent stem cell nanoengineering

More Related Videos

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Related Experiment Videos

Last Updated: Jun 15, 2026

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

Published on: March 28, 2025

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Area of Science:

Biomedical Engineering
Regenerative Medicine
Nanotechnology

Background:

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) show promise for cardiac repair but suffer from immaturity.
Current limitations in hiPSC-CMs hinder their therapeutic efficacy and application.
Nanoscale technologies offer precise control over the cellular microenvironment to guide cell development.

Purpose of the Study:

To review advancements in nanoscale technologies for promoting hiPSC-CMs maturation.
To explore how nanostructures and nanobridges enhance microenvironmental mimicry and deliver biophysical cues.
To assess the application of nanoengineered hiPSC-CMs in cardiac regeneration, drug screening, and disease modeling.

Main Methods:

Review of recent literature on nanoscale engineering in cardiac tissue.
Analysis of nanostructures and nanobridge scaffolds for biophysical stimulation.
Evaluation of nanotechnology-assisted hiPSC-CMs models for various applications.

Main Results:

Nanoscale scaffolds precisely control the cellular microenvironment, influencing hiPSC-CMs alignment, differentiation, and maturation.
Ultra-tiny nanoscale engineering effectively replicates microenvironmental cues essential for hiPSC-CMs maturation.
Nanotechnology facilitates cardiac tissue regeneration, drug screening, and disease modeling.

Conclusions:

Nanoscale engineering is a transformative strategy for maturing hiPSC-CMs, addressing challenges of immaturity.
Nanoengineered hiPSC-CMs models hold significant potential for cardiac regenerative medicine.
Further evaluation of scalability, integration, and physiological relevance is needed for commercialization.